"Prestige Clinical Research Center, Inc. (PCRC) is a Clinical Research Facility, with the experience and history of providing prestigious quality services to Sponsors/CROs. PCRC provides the clinical research industry with an innovative clinical research site, providing a quality and safety to subjects and the Pharmaceutical Industry, in compliance with Good Clinical Practices/ ICH Guidelines."

During the past decade, Prestige Clinical Research Center Inc conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 10 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prestige Clinical Research Center Inc" #1 sponsor was "Pfizer" with 4 trials, followed by "Janssen Vaccines & Prevention B.V." with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prestige Clinical Research Center Inc" #1 collaborator was "CoLucid Pharmaceuticals" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Sucampo AG" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Prestige Clinical Research Center Inc" are "Hyperlipidemia" (3 trials), "Asthma" (1 trials), "COVID-19" (1 trials), "Chronic Idiopathic Constipation" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Prestige Clinical Research Center Inc" in a lesser frequency.

Most popular intervention types in "Prestige Clinical Research Center Inc" are "Drug" (9 trials), "Biological" (4 trials), "Other" (4 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Abilify MyCite®" (1 trials), "Ad26.COV2.S" (1 trials), "Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF" (1 trials) and "Bococizumab (PF-04950615; RN316)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Prestige Clinical Research Center Inc" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Prestige Clinical Research Center Inc". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Prestige Clinical Research Center Inc, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Prestige Clinical Research Center Inc, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".